Moderna, Inc. (MRNA) Cash Flow Statement
Moderna, Inc. (MRNA) generated -$1.1B of operating cash flow over the twelve months to 2026-06-30, spent $171.0M on capital expenditure and had free cash flow of -$1.2B, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
MRNAModerna, Inc.Follow MRNA — free
—
Price chart with a free account
- Market cap
- 79.9B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 6 Nov, in 13 days
| Line | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -0.33 | -0.46 | 2.03 | 13.62 | 4.98 | -3.12 | -3.00 | -1.87 | -1.07 | |
| Capital expenditure | 0.11 | 0.03 | 0.07 | 0.28 | 0.40 | 0.71 | 1.05 | 0.19 | -0.17 | |
| Free cash flow | -0.44 | -0.49 | 1.96 | 13.34 | 4.58 | -3.83 | -4.06 | -2.07 | -1.24 | |
| Share repurchases | — | — | — | 0.86 | 3.33 | 1.15 | 0.00 | 0.00 | — | |
| Stock-based compensation | 0.07 | 0.08 | 0.09 | 0.14 | 0.23 | 0.31 | 0.43 | 0.48 | — |
USD billions · SEC XBRL
Moderna, Inc. — questions
- What is Moderna, Inc.'s operating cash flow?
- -$1.1B over the twelve months to 2026-06-30.
- How much does Moderna, Inc. spend on capital expenditure?
- $171.0M over the twelve months to 2026-06-30.
- What is Moderna, Inc.'s free cash flow?
- -$1.2B over the twelve months to 2026-06-30: operating cash flow minus capital expenditure.
Every figure on this page comes from Moderna, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.